id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0592-0010,FDA,FDA-2008-D-0592,Contents of a Complete Submission for the Evaluation ofProprietary Names - Guidance for Industry,Other,Guidance,2010-02-12T05:00:00Z,2010,2,2010-02-08T05:00:00Z,,2020-04-21T15:30:22Z,,0,0,0900006480a92059
FDA-2008-D-0592-0009,FDA,FDA-2008-D-0592,Guidance for Industry: Contents of Complete Submission for Evaluation of Proprietary Names; Availability,Notice,Notice of Availability,2010-02-08T05:00:00Z,2010,2,2010-02-08T05:00:00Z,,2020-04-21T15:30:43Z,2010-02660,0,0,0900006480a8fa37
FDA-2008-D-0592-0002,FDA,FDA-2008-D-0592,Guidance for Industry on the Contents of a Complete Submission for the Evaluation of Proprietary Names; Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2008-11-24T05:00:00Z,2008,11,,,2009-01-27T18:37:56Z,,0,0,09000064807bd85c
FDA-2008-D-0592-0001,FDA,FDA-2008-D-0592,Draft Guidance for Industry on the Contents of a Complete Submission for the Evaluation of Proprietary Names; Availability,Notice,NAD-Notice of Availability of Data,2008-11-24T05:00:00Z,2008,11,2008-11-24T05:00:00Z,2009-01-24T04:59:59Z,2009-01-27T18:39:41Z,E8-27896,0,0,09000064807bd57c